🇺🇸 FDA

Intelligence · Patent portfolio

ENANTA PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for ENANTA PHARMACEUTICALS — grant dates, expiration, and drug cross-links.

Patents
218
Expiring ≤24m
9

Quick answer

ENANTA PHARMACEUTICALS has 218 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 9 expire within 24 months — use filters for patent-cliff planning.

Page 3 of 5

  1. US 9732110

    Nucleoside and nucleotide derivatives

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9718851

    Deuterated nucleoside/tide derivatives

    Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9676802

    Hepatitis C virus inhibitors

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9675632

    Nucleoside and nucleotide derivatives

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9669095

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9616099

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9603895

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9526769

    Macrocylic oximyl hepatitis C protease inhibitors

    Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9309279

    Macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9221878

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9220748

    Macrocyclic proline derived HCV serine protease inhibitors

    Expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9193740

    Bismacrocyclic compounds as hepatitis C virus inhibitors

    Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9156818

    Hepatitis C virus inhibitors

    Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9156886

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9127021

    Hepatitis C virus inhibitors

    Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9085599

    2′allene-substituted nucleoside derivatives

    Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9060971

    Combination pharmaceutical agents as inhibitors of HCV replication

    Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9000020

    Linked dibenzimidazole antivirals

    Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8962551

    Quinoxalinyl derivatives

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8951998

    Quinoxaline-containing compounds as hepatitis C virus inhibitors

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8951964

    Phenanthridine macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8940688

    Fluorinated tripeptide HCV serine protease inhibitors

    Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8936781

    Macrocyclic compounds as hepatitis C virus inhibitors

    Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8933110

    Hepatitis C virus inhibitors

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8927709

    Hepatitis C virus inhibitors

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8906853

    [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8846638

    Macrocyclic nucleoside phosphoramidate derivatives

    Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8822700

    Hepatitis C virus inhibitors

    Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8815928

    Hepatitis C virus inhibitors

    Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8809264

    Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors

    Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8785487

    Hepatitis C virus inhibitors

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8785377

    Tetrazolyl macrocyclic hepatitis C serine protease inhibitors

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8778938

    Hepatitis C virus inhibitors

    Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8759332

    Hepatitis C virus inhibitors

    Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8703938

    Hepatitis C virus inhibitors

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8697704

    Hepatitis C virus inhibitors

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8685917

    Cyclosporin analogues

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8673954

    Benzimidazole derivatives

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8653070

    Hepatitis C virus inhibitors

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8648037

    Macrocyclic proline derived HCV serine protease inhibitors

    Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8637561

    Linked diimidazole derivatives

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8623814

    Antiviral agents

    Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8609648

    Hepatitis C virus inhibitors

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8575119

    2′-chloroacetylenyl substituted nucleoside derivatives

    Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8507522

    Hepatitis C virus inhibitors

    Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8501682

    Difluorinated tripeptides as HCV serine protease inhibitors

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8501681

    Macrocyclic hepatitis C virus serine protease inhibitors

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8481483

    Cyclosporin analogues

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does ENANTA PHARMACEUTICALS have?

218 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ENANTA PHARMACEUTICALS patents expire?

9 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.